Literature DB >> 24113486

Questions on the role of the EPR effect in tumor targeting.

Kinam Park1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24113486     DOI： 10.1016/j.jconrel.2013.10.001

Source DB:  PubMed          Journal:  J Control Release        ISSN： 0168-3659            Impact factor:   9.776


× No keyword cloud information.
  11 in total

Review 1.  Vascular targeting of nanoparticles for molecular imaging of diseased endothelium.

Authors:  Prabhani U Atukorale; Gil Covarrubias; Lisa Bauer; Efstathios Karathanasis
Journal:  Adv Drug Deliv Rev       Date:  2016-09-15       Impact factor: 15.470

2.  Synthesis and characterisation of ultrasound imageable heat-sensitive liposomes for HIFU therapy.

Authors:  Danny Maples; Kevin McLean; Kaustuv Sahoo; Ryan Newhardt; Perumal Venkatesan; Bradford Wood; Ashish Ranjan
Journal:  Int J Hyperthermia       Date:  2015-07-17       Impact factor: 3.914

3.  DNA Thioaptamer with Homing Specificity to Lymphoma Bone Marrow Involvement.

Authors:  Junhua Mai; Xin Li; Guodong Zhang; Yi Huang; Rong Xu; Qi Shen; Ganesh L Lokesh; Varatharasa Thiviyanathan; Lingxiao Chen; Haoran Liu; Youli Zu; Xiaojing Ma; David E Volk; David G Gorenstein; Mauro Ferrari; Haifa Shen
Journal:  Mol Pharm       Date:  2018-03-26       Impact factor: 4.939

Review 4.  Crossing the barrier: treatment of brain tumors using nanochain particles.

Authors:  Efstathios Karathanasis; Ketan B Ghaghada
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-01-09

5.  Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles.

Authors:  Mehdi Esfandyari-Manesh; Seyed Hossein Mostafavi; Reza Faridi Majidi; Mona Noori Koopaei; Nazanin Shabani Ravari; Mohsen Amini; Behrad Darvishi; Seyed Nasser Ostad; Fatemeh Atyabi; Rassoul Dinarvand
Journal:  Daru       Date:  2015-04-23       Impact factor: 3.117

Review 6.  Thermosensitive liposomal drug delivery systems: state of the art review.

Authors:  Barbara Kneidl; Michael Peller; Gerhard Winter; Lars H Lindner; Martin Hossann
Journal:  Int J Nanomedicine       Date:  2014-09-16

7.  A multi-functional nanoplatform for efficacy tumor theranostic applications.

Authors:  Jinjin Shi; Hongling Zhang; Zhaoyang Chen; Lihua Xu; Zhenzhong Zhang
Journal:  Asian J Pharm Sci       Date:  2016-12-21       Impact factor: 6.598

8.  A New Concept of Enhancing Immuno-Chemotherapeutic Effects Against B16F10 Tumor via Systemic Administration by Taking Advantages of the Limitation of EPR Effect.

Authors:  Yuting Yang; Xiaowei Tai; Kairong Shi; Shaobo Ruan; Yue Qiu; Zhirong Zhang; Bing Xiang; Qin He
Journal:  Theranostics       Date:  2016-09-12       Impact factor: 11.556

9.  Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs.

Authors:  Hiroshi Maeda; Mahin Khatami
Journal:  Clin Transl Med       Date:  2018-03-01

10.  EPR-Effect Enhancers Strongly Potentiate Tumor-Targeted Delivery of Nanomedicines to Advanced Cancers: Further Extension to Enhancement of the Therapeutic Effect.

Authors:  Waliul Islam; Shintaro Kimura; Rayhanul Islam; Ayaka Harada; Katsuhiko Ono; Jun Fang; Takuro Niidome; Tomohiro Sawa; Hiroshi Maeda
Journal:  J Pers Med       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.